Dr. Mike Sharma and Dr. C. Michael Gibson Discuss: AXIOMATIC-SSP: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention August 28, 2022 Disclosures: TBA
Dr. Ashkan Shoamanesh and Dr. C. Michael Gibson Discuss: PACIFIC-STROKE – Phase 2 Program of AntiCoagulation via Inhibition of FXIa by the oral Compound BAY 2433334 – non-cardioembolic STROKE study August 28, 2022 Disclosure: TBA
Dr. John Alexander and Dr. C. Michael Gibson Discuss: PACIFIC-AMI – Efficacy and safety of factor XIa inhibitor asundexian on top of dual antiplatelet therapy after acute myocardial infarction August 28, 2022 Disclosure: TBA
Dr. Ganesan Karthikeyan and Dr. C. Michael Gibson Discuss: INVICTUS – Rivaroxaban versus VKA for rheumatic atrial fibrillation August 28, 2022 Disclosures: TBA
Dr. Scott Solomon, Dr. Pardeep Jhund, Dr. Muthiah Vaduganathan, and Dr. C. Michael Gibson Discuss: DELIVER – Dapagliflozin in Heart Failure with Mildly Reduced and Preserved Ejection Fraction August 27, 2022 Disclosures: TBA
Snackable Health® with Dr. Gibson and Dr. Kohli: Dr. Payal Kohli and I discuss ways to identify and prevent Monkeypox August 23, 2022 Disclosures: TBD
Dr. Bryon Cryer and Dr. C. Michael Gibson Discuss: Gastrointestinal Toxicity of Aspirin: the Pathophysiology of the Problem and the Pathophysiologically Guided Solution August 23, 2022 Disclosures: TBD
Dr. Jonathan Reiner and Dr. C. Michael Gibson Discuss: What the Best Path Forward for the CDC Might Look Like August 18, 2022 Disclosures: TBD
Snackable Health® with Dr. Gibson and Dr. Kohli: Dr. Payal Kohli and I discuss the resurgence of Polio August 17, 2022 Disclosures: TBD
Snackable Health® with Dr. Gibson and Dr. Kohli: Dr. Payal Kohli and I discuss the new updates to the CDC guidance for COVID August 16, 2022 Disclosures: TBD
